glp 1 dose conversion chart Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy Designing GLP-1 delivery: structural perspectives
Description
Any decision to discontinue tirzepatide should be made in close consultation with your Centra Internal Medicine provider, based on your individual response and overall health status
The majority of GLP-1 medications are only approved for adults 18 years and older
Nausea, diarrhea, and vomiting were the most common events
Five clinical trials (SURPASS 1-5 trials) conducted in patients with T2DM showed that tirzepatide at 5-15 mg per week could reduce body weight (5.4-11.7kg), which was never seen with a single drug (129)
From December 2024 to January 2, 2025, 31 people joined the MDL
